Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Whitters

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Experimental Medicine|March 19, 2003
Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2Nancy Wood, Matthew J Whitters, Bruce A Jacobson, et al.
The Journal of Biological Chemistry|March 16, 2007
Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cellsJill F Wright, Yongjing Guo, Amira Quazi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2008
The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complexJill F Wright, Frann Bennett, Bilian Li, et al.
European Journal of Immunology|June 9, 2012
Enhanced GITR/GITRL interactions augment IL-27 expression and induce IL-10-producing Tr-1 like cellsYijun Carrier, Matthew J Whitters, Joy S Miyashiro, et al.
Arthritis and Rheumatism|March 30, 2007
Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritisDeborah A Young, Martin Hegen, Hak Ling Margery Ma, et al.
Immunity|April 24, 2002
IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunityMarion T Kasaian, Matthew J Whitters, Laura L Carter, et al.
Mabs|September 3, 2013
CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous deliveryBrian J Fennell, Barry McDonnell, Amy Sze Pui Tam, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Experimental Medicine|March 19, 2003
Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2Nancy Wood, Matthew J Whitters, Bruce A Jacobson, et al.
The Journal of Biological Chemistry|March 16, 2007
Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cellsJill F Wright, Yongjing Guo, Amira Quazi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2008
The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complexJill F Wright, Frann Bennett, Bilian Li, et al.
European Journal of Immunology|June 9, 2012
Enhanced GITR/GITRL interactions augment IL-27 expression and induce IL-10-producing Tr-1 like cellsYijun Carrier, Matthew J Whitters, Joy S Miyashiro, et al.
Arthritis and Rheumatism|March 30, 2007
Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritisDeborah A Young, Martin Hegen, Hak Ling Margery Ma, et al.
Immunity|April 24, 2002
IL-21 limits NK cell responses and promotes antigen-specific T cell activation: a mediator of the transition from innate to adaptive immunityMarion T Kasaian, Matthew J Whitters, Laura L Carter, et al.
Mabs|September 3, 2013
CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous deliveryBrian J Fennell, Barry McDonnell, Amy Sze Pui Tam, et al.
Pageof 2